Image for representational purpose only (File photo | PTI) 
India

CCMB scientists find different variant of SARS-CoV-2 in South India

Rakesh Mishra, director of CCMB, said the different variant (N440K) appears to be milder than the existing one and the institute is stepping up research on it.

PTI

HYDERABAD: Scientists at the CSIR-Centre for Cellular and Molecular Biology here have found prominently a different variant of SARS-CoV-2 in southern parts of India, a top official of the institute said on Thursday.

Rakesh Mishra, director of CCMB, said the different variant (N440K) appears to be milder than the existing one and the institute is stepping up research on it to ascertain its prevalence in the country.

The findings came amid the concerns of a mutated variant of SARS-CoV-2found in the UK recently.

"It is not a new variant that we found. It is N440 K. It is a different variant. This is there for some time. This N440K was a very small number in September and October last year. Now it looks like it is getting a much bigger proportion. No symptoms issues with N440K," Mishra told PTI.

"Either this (the differentvariant) has become normal or the earlier one became weaker. But certainly symptom wise if it is not equal, it (the differentone) is milder. We dont have enough data as of now. We are accelerating. I think in coming days we will do large-scale sequencing," he explained.

He said the variant is seen in Telangana and Andhra Pradesh and other southern states and scientists have no sufficient data to prove its existence in other parts of the country.

Mishra said the CCMB did not see any increased number of cases or symptoms with this variant of the virus.

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’